Radical Hysterectomy: Evolution Of Surgical Approach and Related Outcomes
NCT ID: NCT03577613
Last Updated: 2018-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
188 participants
OBSERVATIONAL
1999-05-01
2016-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics
NCT01761721
Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer
NCT01658930
Comparison of Three Robotic Platforms for Hysterectomy
NCT06138197
Robotic-assisted Hysterectomy: Single- vs. Multi-port Laparoscopic Access
NCT03373513
Laparoscopic vs Abdominal Radical Hysterectomy In Patients With Early Cervical Cancer
NCT01258413
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Interventions: Patients underwent an open radical hysterectomy (ORH) or minimally invasive surgery (MIS): laparoscopic (LRH) or robotically assisted radical hysterectomy (RRH).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early stage Cervical Cancer- Open Radical Hysterectomy(RH)
Patients who were clinically diagnosed with FIGO stage IA2-IB1-IIA1 cervical cancer and underwent a open RH at our institution as primary treatment were included in the study
Open radical hysterectomy
Early stage Cervical Cancer- Laparoscopic Radical Hysterectomy
Patients who were clinically diagnosed with FIGO stage IA2-IB1-IIA1 cervical cancer and underwent a laparoscopic RH at our institution as primary treatment were included in the study
laparoscopic radical hysterectomy
Early stage Cervical Cancer- Robotic radical Hysterectomy(RRH)
Patients who were clinically diagnosed with FIGO stage IA2-IB1-IIA1 cervical cancer and underwent a robotically assisted RH at our institution as primary treatment were included in the study
Robotically assisted radical hysterectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Open radical hysterectomy
laparoscopic radical hysterectomy
Robotically assisted radical hysterectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjected to Radical Hysterectomy.
Exclusion Criteria
* Previous chemotherapy treatment
* Previous pelvic radiotherapy
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitari Vall d'Hebron Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonio Gil-Moreno, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Vall D'Hberon
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR(AMI)23/1999
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.